LUPIN

Lupin Limited

Other · BOTH

Thu, 8 Oct, 2026
- FilingLupin receives U.S. FDA approval for Phytonadione Injectable Emulsion, USP BSE ↗
- Filing
  Lupin receives U.S. FDA approval for Phytonadione Injectable Emulsion, USP
  NSE ↗
Tue, 6 Oct, 2026
- Filing
  Lupin launches Formoflo-G MDI, a fixed-dose triple combination for COPD management
  BSE ↗
Thu, 1 Oct, 2026
- Filing
  Multicare Pharmaceuticals Philippines completed share buyback, making it a step-down wholly owned subsidiary of Lupin e…
  NSE ↗
- FilingMulticare Pharmaceuticals Philippines completed buyback of 30,559 shares, making it a step-down wholly owned subsidiary BSE ↗
Mon, 28 Sept, 2026
- FilingLupin receives tentative FDA approval for novel apixaban oral suspension formulation NSE ↗
- Filing
  Lupin receives tentative FDA approval for apixaban oral suspension, a novel anticoagulant formulation
  BSE ↗
Mon, 7 Sept, 2026
- News
  Lupin receives USFDA approval for Modafinil tablets
  moneycontrol.com ↗
Fri, 4 Sept, 2026
- Filing
  Press release filed on Lupin receiving U.S. FDA approval for Modafinil Tablets, USP
  NSE ↗
- Filing
  Lupin receives U.S. FDA approval for Modafinil Tablets, USP
  BSE ↗
Thu, 20 Aug, 2026
- News
  Lupin subsidiary to commercialize YUVEZZI eye drop in European markets
  economictimes.indiatimes.com ↗
- FilingVISUfarma subsidiary enters exclusive license agreement with Visus Therapeutics for therapeutic development rights NSE ↗
- Filing
  Wholly owned subsidiary entered into an exclusive license agreement with Visus Therapeutics, Inc. U.S.A
  BSE ↗
Wed, 19 Aug, 2026
- News
  Lupin received USFDA approval for a drug to treat excessive daytime sleepiness
  m.economictimes.com ↗
Tue, 18 Aug, 2026
- News
  Economic Times news article about USFDA approval for Lupin's drug
  m.economictimes.com ↗
Mon, 17 Aug, 2026
- Filing
  Lupin announced FDA approval for Pitolisant Tablets, a new pharmaceutical product
  NSE ↗
- Filing
  Lupin receives U.S. FDA approval for Pitolisant Tablets, a once-daily narcolepsy treatment
  BSE ↗
Mon, 10 Aug, 2026
- Filing
  Lupin announces FDA approval of Sodium Zirconium Cyclosilicate oral suspension in the United States
  NSE ↗
- Filing
  Lupin announces FDA approval of Sodium Zirconium Cyclosilicate for Oral Suspension in the United States
  BSE ↗
Fri, 7 Aug, 2026
- News
  Lupin Q1 PAT rises 16% to Rs 1,417 crore
  m.economictimes.com ↗

Get LUPIN on your morning brief.

A calm daily reading of the filings on the stocks you actually hold — cited, no tips.

Begin